SCRIPT 2026 TESTED QUESTIONS WITH
COMPLETE ANSWERS
⩥ Tx for intermittent asthma. Answer: step 1
⩥ Mild asthma. Answer: Sx >/2days/week but not daily
pm awakenings 3-4x/month
SABA use >2 days/week but not daily
minor limitation
⩥ Intermittent asthma lung function. Answer: normal FEV1 bt
exacerbations
FEV1>80% predicted
FEV1/FVC normal
⩥ Mild asthma lung function. Answer: FEV1>80% pred.
FEV1/FVC normal
⩥ Mild asthma tx. Answer: Step 2
⩥ Moderate asthma. Answer: Sx: daily
,PM awakenings: >1x/week but not nightly
SABA use: daily
some limiation
⩥ mod. asthma lung function. Answer: 60<FEV1<80 predicted
FEV1/FVC reduced 5%
⩥ Mod. asthma tx. Answer: step 3 and consider shot course of oral
steroid
⩥ Severe asthma. Answer: Sx: thruout day
pm awakenings: often 7x/week
extremely limited
⩥ severe asthma lung function. Answer: FEV1<60% predicted
FEV1/FVC reduced >5%
⩥ severe asthma lung function tx. Answer: step 4 or 5 and consider short
course of steroids
⩥ Asthma step 1. Answer: SABA prn
, ⩥ Asthma Step 2. Answer: low dose ICS
ALT- cromolyn, LTRA, nedocromil or theophylline
⩥ Asthma step 3. Answer: low dose ICS + LABA
or- medium dose ICS
⩥ Asthma step 4. Answer: medium dose ICS + LABA
⩥ Asthma step 5. Answer: high dose ICS + LABA
AND
consider omalizumab for patients with allergies
⩥ Asthma step 6. Answer: High dose ICS + LABA + oral corticosteroid
AND
consider omalizumab for pts with allergies
⩥ Asthma monitoring for acute episode. Answer: f/u in 1-2 hours or next
day until pt is stable
then q3-5 days, then weekly until sx are controlled and peak flow
consistently 80% of predicted, then monthly until under control for at
least 3 months
⩥ IDA. Answer: MCH<23